Richard Bucala is Chief of the Section of Rheumatology, Allergy, and Immunology and the Waldemar Von Zedtwitz Endowed Professor of Medicine, Pathology, and Epidemiology and Public Health. He
studies the regulation of the immune system, with a focus on how protective responses can lead to immunopathology and disease. His laboratory’s main emphasis is MIF-family cytokines, their role in genetic susceptibility to disease, and their therapeutic targeting for different clinical conditions. He received a BS and MS from Yale University and a PhD from Rockefeller University. He obtained an MD from Cornell College and completed his residency at the Brigham and Women's Hospital/Harvard Medical School. He co-founded two biotechnology companies, including the startup MIFCOR, began as a student-advised project. He attends the Yale New Haven Health System inpatient service and is the past Editor-in-Chief of Arthritis and Rheumatology. He was elected to the American Society for Clinical Investigation and the Association of American Physicians and has served on advisory boards for the UN, the federal government, the pharmaceutical industry, academia, and private foundations.
